ORAL MUSCLE RELAXANTS WITH NONSPECIFIC BACK PAIN


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper considers the issues of oral muscle relaxant treatment for nonspecific back pain.

Full Text

Restricted Access

About the authors

N. Maslova

Smolensk State Medical University

K. Agafonov

Smolensk Regional Clinical Hospital

Email: agafonova.marina.sm@mail.ru

References

  1. Davies C., Nitz A., Mattacola C. et al. Practice patterns when treating patients with low back pain: a survey of physical therapists // Physiother. Theor. Pract. -2014; 30 (6): 399-408.
  2. Hoy D., March L., Brooks P. et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study // Ann. Rheum. Dis. -2014; 73: 968-74.
  3. Itz C., Ramaekers B., van Kleef M., et al. Medical specialists care and hospital costs for low back pain in the Netherlands // Eur. J. Pain. - 2016; 71 (4): 705-15.
  4. Le T., Montejano L., Cao Z. et al. Health care costs in US patients with and without a diagnosis of osteoarthritis // J. Pain Research. - 2012; 5: 23-30.
  5. Deyo R., Weinstein J. Low Back Pain // N. Engl. J. Med. - 2001; 344 (5): 363-70.
  6. Bogduk N., McGuirk B. Medical management of acute at chronic low back pain / Amsterdam: Elsevier, 2002.
  7. Dugan S. The role of exercise in the prevention and management of acute low back pain // Clin. Occup. Environ. Med. - 2006; 5: 615-32.
  8. Van Tulder M., Becker A., Bekkering T. et al. European guidelines for the management of acute nonspecific low back pain in primary care // Eur. Spine J. -2006; 15 (2): 169-91.
  9. Liu P., Guo W., Zhao X. et al. Intrathecal baclofen, a GABAB receptor agonist, inhibits the expression of p-CREB and NR2B in the spinal dorsal horn in rats with diabetic neuropathic pain // Can. J. Physiol. Pharmacol. - 2014; 92 (8): 655-60.
  10. Huang D., Huang S., Peers C. et al. GABAB receptors inhibit low-voltage activated and high-voltage activated Ca(2+) channels in sensory neurons via distinct mechanisms // Biochem. Biophys. Res. Commun. - 2015; 465 (2): 188-93.
  11. Narendran R., Duarte R., Valyi A. et al. The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database // BMJ Open. - 2015; 5 (6): e007517.
  12. Zaringhalam J., Manaheji H., Rastqar A. et al. Reduction of chronic nonspecific low back pain: A randomised controlled clinical trial on acupuncture and baclofen // Chin. Med. - 2010; 5: 15.
  13. Al-Quliti K. Update on neuropathic pain treatment for trigeminal neuralgia. The pharmacological and surgical options // Neurosciences (Riyadh). - 2015; 2: 107-14.
  14. Ringel R., Roy E. Glossopharyngeal neuralgia: successful treatment with baclofen // Ann. Neurol. - 1987; 21 (5): 514-5.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies